ALTEOGEN revenue and financials

196170 · KRX · KRW

₩259,500.00Change from previous close: −2.08%Absolute change: −₩5,500.00

Close · October 2, 2026

In the fiscal year ended December 2025, ALTEOGEN reported revenue of ₩215.86B (+109.87% year over year). Net income was ₩141.67B, a net margin of 65.6%.

Annual revenue · 2025: ₩215.86B
  1. ₩28.81B2022
  2. ₩96.52B2023
  3. ₩102.85B2024
  4. ₩215.86B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+109.87%
2025 vs 2024
Net income growth
+127.57%
2025 vs 2024
Net margin
65.6%
2024: 60.5%

Financial data

Amounts in millions of KRW; per-share values in KRW; shares in millions.

Balance sheet · Annual
Item20252024202320222021
Total assets698,743409,012256,100245,490—
Current assets480,795211,785144,076145,095—
Cash and equivalents66,38118,99430,20045,829—
Short-term investments363,641166,25980,40881,710—
Inventory6,5309571,0681,575—
Net property, plant and equipment40,87819,61819,28827,243—
Goodwill—113113113113
Other intangible assets120,119112,02689,21847,187—
Long-term investments931————
Current liabilities239,684129,186100,41594,309—
Accounts payable11,18010,0411,013160—
Long-term debt4,0285,0001,249688—
Total debt7,05911,7591,7054,327—
Total liabilities244,300134,921108,258100,108—
Total equity (incl. minority)454,443274,091147,842145,382—
Retained earnings218,53876,87214,62017,991—
Minority interest9,249498-273-3,377—